SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193805-14-000998
Filing Date
2014-05-15
Accepted
2014-05-15 17:13:04
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 e612271_10q-retrophin.htm 10-Q 759965
2 e612271_ex31-1.htm EX-31.1 14618
3 e612271_ex31-2.htm EX-31.2 14595
4 e612271_ex32-1.htm EX-32.1 5721
5 e612271_ex32-2.htm EX-32.2 5842
  Complete submission text file 0001193805-14-000998.txt   4602959

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rtrx-20140331.xml EX-101.INS 659780
7 XBRL TAXONOMY EXTENSION SCHEMA rtrx-20140331.xsd EX-101.SCH 44089
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rtrx-20140331_cal.xml EX-101.CAL 51768
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rtrx-20140331_def.xml EX-101.DEF 72679
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rtrx-20140331_lab.xml EX-101.LAB 274245
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rtrx-20140331_pre.xml EX-101.PRE 185204
Mailing Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017 212-983-1310
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 0229
Type: 10-Q | Act: 34 | File No.: 001-36257 | Film No.: 14848812
SIC: 2834 Pharmaceutical Preparations